Literature DB >> 20789897

To-day's Drugs.

.   

Abstract

Year:  1963        PMID： 20789897      PMCID： PMC1872223     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  16 in total

1.  A clinical trial of Persantin and Crodimyl in the treatment of angina of effort.

Authors:  H A DEWAR; A R HORLER
Journal:  Scott Med J       Date:  1961-04       Impact factor: 0.729

2.  Observations on the coronary vasodilator effect of 'persantin'.

Authors:  A A PEEL; K BLUM; W M LANCASTER; J L DALL; G L CHALMERS
Journal:  Scott Med J       Date:  1961-09       Impact factor: 0.729

3.  A clinical trial of penta-erythritol tetranitrate, a khellin derivative (recordil), and iproniazid in angina of effort.

Authors:  H A DEWAR; A R HORLER; D J NEWELL
Journal:  Br Heart J       Date:  1959-07

4.  Controlled double-blind trial of "persantin" in treatment of angina pectoris.

Authors:  T FOULDS; J MACKINNON
Journal:  Br Med J       Date:  1960-09-17

5.  Isosorbide dinitrate in angina pectoris.

Authors:  L G JOSEPH; A MANCINI
Journal:  Angiology       Date:  1961-06       Impact factor: 3.619

6.  Clinical trial of two coronary vasodilator drugs.

Authors:  E H PARRY; P G WELLS
Journal:  Br Med J       Date:  1960-01-02

7.  Assay of anti-anginal agents. I. A curve analysis with multiple control periods.

Authors:  S L COLE; H KAYE; G C GRIFFITH
Journal:  Circulation       Date:  1957-03       Impact factor: 29.690

8.  Long-acting coronary vasodilator drugs: metamine, paveril, nitroglyn and peritrate.

Authors:  H I RUSSEK; B L ZOHMAN; A E DRUMM; W WEINGARTEN; V J DORSET
Journal:  Circulation       Date:  1955-08       Impact factor: 29.690

9.  Failure of propatylnitrate and pentaerythritol tetranitrate to prevent attacks of angina pectoris.

Authors:  S ORAM; E SOWTON
Journal:  Br Med J       Date:  1961-12-30

10.  A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort; a study of khellin (visammin).

Authors:  T GREINER; H GOLD; M CATTELL; J TRAVELL; H BAKST; S H RINZLER; Z H BENJAMIN; L J WARSHAW; A L BOBB; N T KWIT; W MODELL; H H ROTHENDLER; C R MESSELOFF; M L KRAMER
Journal:  Am J Med       Date:  1950-08       Impact factor: 4.965
View more
  1 in total

Review 1.  Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.

Authors:  Rashmi R Shah; Peter D Stonier
Journal:  Ther Adv Drug Saf       Date:  2018-06-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.